RN316
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RN316, covering 2015-04-23 to 2015-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia [Phase 1]